These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6778941)

  • 1. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
    Hoyer LW; Trabold NC
    J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
    Switzer ME; McKee PA
    J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.
    Cooper HA; Reisner FF; Hall M; Wagner RH
    J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of factor VIII inactivation by human antibodies. III. Proteolytic cleavage of factor VIII:C and C antigen by thrombin.
    Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
    Ann Clin Lab Sci; 1985; 15(6):482-7. PubMed ID: 3933404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
    Tran TH; Duckert F
    Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of factor VIII inactivation by human antibodies. IV. Antibody binding prevents factor VIII proteolysis by thrombin.
    Lazarchick J; Ashby MA; Lazarchick JJ; Sens DA
    Ann Clin Lab Sci; 1986; 16(6):497-501. PubMed ID: 3099625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
    Tran TH; Marbet GA; Duckert F
    Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
    Kirby EP
    Thromb Haemost; 1981 Aug; 46(2):479-84. PubMed ID: 6795738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subunit structure of normal and hemophilic factor VIII.
    Shapiro GA; Andersen JC; Pizzo SV; McKee PA
    J Clin Invest; 1973 Sep; 52(9):2198-210. PubMed ID: 4199414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolysis of blood coagulation factor VIII by the factor VIIa-tissue factor complex: generation of an inactive factor VIII cofactor.
    Warren DL; Morrissey JH; Neuenschwander PF
    Biochemistry; 1999 May; 38(20):6529-36. PubMed ID: 10350471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.
    De Cristofaro R; De Filippis V
    Biochem J; 2003 Jul; 373(Pt 2):593-601. PubMed ID: 12689334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inactivation of hemostatic factors by hematin.
    Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
    J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of factor VIII by a mechanism independent of the generation of thrombin.
    Triantaphyllopoulos DC
    Thromb Haemost; 1979 Oct; 42(3):838-47. PubMed ID: 505401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution to the isolation and study of the molecular weight of human factor VIII].
    Mazurier C; Parquet-Gernez A; Goudemand M; Montreuil J
    Pathol Biol (Paris); 1975 Dec; 23 suppl():11-6. PubMed ID: 57588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin.
    Vukovich T; Koller E; Doleschel W
    Thromb Haemost; 1979 Oct; 42(3):832-7. PubMed ID: 505400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of human factor VIII. I. Characterization of factor VIII present in the supernatant of cryoprecipitate.
    Over J; Bouma BN; van Mourik JA; Sixma JJ; Vlooswijk R; Bakker-Woudenberg I
    J Lab Clin Med; 1978 Jan; 91(1):32-46. PubMed ID: 618989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies to human procoagulant factor VIII.
    Rotblat F; Goodall AH; O'Brien DP; Rawlings E; Middleton S; Tuddenham EG
    J Lab Clin Med; 1983 May; 101(5):736-46. PubMed ID: 6403638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII).
    Pittman DD; Kaufman RJ
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2429-33. PubMed ID: 3128786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.